Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASYlight
2023-508417-16-00Phase 4Authorised
- Sponsor
- Reinier de Graaf Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in endometriosis and chronic prostatitis (CP), sponsored by Reinier de Graaf Hospital. Planned start Jan 2024; status: authorised.
02
Drugs
esketamine
03
Conditions
endometriosischronic prostatitis (CP)
Beyond the preview
Go deeper on 2023-508417-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508417-16-00.